멜라토닌과 정신과 질환

키워드

참고문헌 (64)

1. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders: DSM-5" (2013), American Psychiatric Publishing
2. Ancoli-Israel S., "Sleep and aging: prevalence of disturbed sleep and treatment considerations in older adults", J Clin Psychiatry, 66(Suppl 9), pp.24~30 (2005)
3. Ancoli-Israel S, "Sleep in the elderly: normal variations and common sleep disorders", Harv Rev Psychiatry, 16, pp.279~286 (2008)
4. Arendt J., "Melatonin: a new probe in psychiatric investigation?", Br J Psychiatry, 155, pp.585~590 (1989)
5. Bartness TJ, "Mammalian pineal melatonin: a clock for all seasons", Experientia, 45, pp.939~945 (1989)
6. Benedetti F, "Morning sunlight reduces length of hospitalization in bipolar depression", J Affect Disord, 62, pp.221~223 (2001)
7. Benedetti F, "Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene", Biol Psychiatry, 54, pp.687~692 (2003)
8. Benedetti F, "Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression", Chronobiol Int, 24, pp.921~937 (2007)
9. Bersani G, "Melatonin add-on in manic patients with treatment resistant insomnia", Prog Neuropsychopharmacol Biol Psychiatry, 24, pp.185~191 (2000)
10. Brunner P, "Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer’s disease", Eur J Histochem, 50, pp.311~316 (2006)
11. Colombo C, "Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: replication of main effects and interaction", Psychiatry Res, 95, pp.43~53 (2000)
12. Cortesi F, "Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial", J Sleep Res, 21, pp.700~709 (2012)
13. Delagrange P, "Therapeutic potential of melatonin ligands", Chronobiol Int, 23, pp.413~418 (2006)
14. Dowling GA, "Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer’s disease", J Am Geriatr Soc, 56, pp.239~246 (2008)
15. Dubocovich ML, "Functional MT1 and MT2 melatonin receptors in mammals", Endocrine, 27, pp.101~110 (2005)
16. Eastman CI, "Bright light treatment of winter depression: a placebo-controlled trial", Arch Gen Psychiatry, 55, pp.883~889 (1998)
17. Ferrari E, "Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia", Exp Gerontol, 35, pp.1239~1250 (2000)
18. Fornaro M, "Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study", Neuropsychiatric Disease and Treatment, 9, pp.243~251 (2013)
19. Gringras P, "Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial", BMJ, 345, pp.e6664~ (2012)
20. Grunhaus L, "Coadministration of melatonin and fluoxetine does not improve the 3-month outcome following ECT", J ECT, 17, pp.124~128 (2001)
21. Hallam KT, "The heritability of melatonin secretion and sensitivity to bright nocturnal light in twins", Psychoneuroendocrinology, 31, pp.867~875 (2006)
22. Kasper S, "Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline", J Clin Psychiatry, 71, pp.109~120 (2010)
23. Kennedy SH, "Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder", Psychiatry Res, 63, pp.219~222 (1996)
24. Kennedy SH, "Melatonin and cortisol “switches” during mania, depression, and euthymia in a drug-free bipolar patient", J Nerv Ment Dis, 177, pp.300~303 (1989)
25. 이현아, "인체의 일주기리듬", 수면정신생리, 21(2), pp.51~60 (2014), 대한수면의학회
26. Lemoine P, "Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine", J Clin Psychiatry, 68, pp.1723~1732 (2007)
27. Lewy AJ, "Supersensitivity to light: possible trait marker for manic-depressive illness", Am J Psychiatry, 142, pp.725~727 (1985)
28. Lewy AJ, "Melatonin and human chronobiology", Cold Spring Harb Symp Quant Biol, 72, pp.623~636 (2007)
29. Lewy AJ, "The circadian basis of winter depression", Proc Natl Acad Sci U S A, 103, pp.7414~7419 (2006)
30. Luboshitzky R, "Actigraphic sleep-wake patterns and urinary 6-sulfatoxymelatonin excretion in patients with Alzheimer’s disease", Chronobiol Int, 18, pp.513~524 (2001)
31. Lynch HJ, "The measurement of melatonin in mammalian tissues and body fluids", J Neural Transm Suppl, pp.251~264 (1978)
32. Mahlberg R, "Pineal calcification in Alzheimer’s disease: an in vivo study using computed tomography", Neurobiol Aging, 29, pp.203~209 (2008)
33. Melke J, "Abnormal melatonin synthesis in autism spectrum disorders", Mol Psychiatry, 13, pp.90~98 (2008)
34. Montgomery SA, "Severe depression and antidepressants:focus on a pooled analysis of placebo-controlled studies on agomelatine", Int Clin Psychopharmacol, 22, pp.283~291 (2007)
35. Murphy MJ, "Sleep Disturbances in Depression", Sleep Med Clin, 10, pp.17~23 (2015)
36. Nagy AD, "Melatonin adjusts the expression pattern of clock genes in the suprachiasmatic nucleus and induces antidepressant-like effect in a mouse model of seasonal affective disorder", Chronobiology International, 32, pp.447~457 (2015)
37. Nathan PJ, "Melatonin sensitivity to dim white light in affective disorders", Neuropsychopharmacology, 21, pp.408~413 (1999)
38. Nosjean O, "Identification of the melatonin-binding site MT3 as the quinone reductase 2", J Biol Chem, 275, pp.31311~31317 (2000)
39. Nurnberger JI Jr, "Melatonin suppression by light in euthymic bipolar and unipolar patients", Arch Gen Psychiatry, 57, pp.572~579 (2000)
40. Pandi-Perumal SR, "Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways", Prog Neurobiol, 85, pp.335~353 (2008)
41. Parry BL, "Increased melatonin and delayed offset in menopausal depression: role of years past menopause, follicle-stimulating hormone, sleep end time, and body mass index", J Clin Endocrinol Metab, 93, pp.54~60 (2008)
42. Pjrek E, "Agomelatine in the treatment of seasonal affective disorder", Psychopharmacology (Berl), 190, pp.575~579 (2007)
43. Quera-Salva MA, "Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients", Int Clin Psychopharmacol, 26, pp.252~262 (2011)
44. Rao AV, "Urinary melatonin in depression", Indian J Psychiatry, 25, pp.167~172 (1983)
45. Sack RL, "Morning vs evening light treatment for winter depression. Evidence that the therapeutic effects of light are mediated by circadian phase shifts", Arch Gen Psychiatry, 47, pp.343~351 (1990)
46. Savaskan E, "Reduced hippocampal MT2 melatonin receptor expression in Alzheimer’s disease", J Pineal Res, 38, pp.10~16 (2005)
47. Savaskan E, "Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer’s disease patients", J Pineal Res, 32, pp.59~62 (2002)
48. Singer C, "A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease", Sleep, 26, pp.893~901 (2003)
49. Skene DJ, "Melatonin rhythmicity: effect of age and Alzheimer’s disease", Exp Gerontol, 38, pp.199~206 (2003)
50. Srinivasan V, "Melatonin in mood disorders", World J Biol Psychiatry, 7, pp.138~151 (2006)
51. Terman JS, "Circadian time of morning light administration and therapeutic response in winter depression", Arch Gen Psychiatry, 58, pp.69~75 (2001)
52. Thorpe M, "Agomelatine-associated manic switch in bipolar depression: a case report", Aust N Z J Psychiatry, 48, pp.958~959 (2014)
53. van Someren EJ, "Circadian rest-activity rhythm disturbances in Alzheimer’s disease", Biol Psychiatry, 40, pp.259~270 (1996)
54. Wahlund B, "Affective disorder subtyped by psychomotor symptoms, monoamine oxidase, melatonin and cortisol: identification of patients with latent bipolar disorder", Eur Arch Psychiatry Clin Neurosci, 248, pp.215~224 (1998)
55. Wehr TA, "A circadian signal of change of season in patients with seasonal affective disorder", Arch Gen Psychiatry, 58, pp.1108~1114 (2001)
56. Weitzman ED, "Studies of the 24 hour rhythm of melatonin in man", J Neural Transm Suppl, pp.325~337 (1978)
57. Wetterberg L, "Clinical importance of melatonin", Prog Brain Res, 52, pp.539~547 (1979)
58. Wirojanan J, "The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome", J Clin Sleep Med, 5, pp.145~150 (2009)
59. Wirz-Justice A, "A rapid-cycling bipolar patient treated with long nights, bedrest, and light", Biol Psychiatry, 45, pp.1075~1077 (1999)
60. Wright B, "Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial", J Autism Dev Disord, 41, pp.175~184 (2011)
61. Wu YH, "Pineal clock gene oscillation is disturbed in Alzheimer’s disease, due to functional disconnection from the “master clock”", FASEB J, 20, pp.1874~1876 (2006)
62. Wu YH, "Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer’s disease", Sleep Med, 8, pp.623~636 (2007)
63. Wu YH, "Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer’s disease", Neurobiol Aging, 28, pp.1239~1247 (2007)
64. Yatham LN, "Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial", Br J Psychiatry (2015)[DOI]

관련 논문AI추천